Diag Capital Management »

Zai Lab shares owned by Diag Capital Management

Quarter-by-quarter ownership of Zai Lab (ZLAB) shares owned by Diag Capital Management from 13F filings

Historical chart of Diag Capital Management investment in Zai Lab

Tip: Access up to 7 years of quarterly data

All positions including Zai Lab held by Diag Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zai Lab by Diag Capital Management

Quarter filed Position value Share count Share price at filing
2018-12-31 $2.8M 120k 23.22

More positions owned by Diag Capital Management

Baxter International (BAX)
Athenex
Zimmer Holdings (ZBH)
Abbvie (ABBV)
Incyte Corporation (INCY)
Quanterix Ord (QTRX)
Celgene Corporation
Amgen (AMGN)
Foamix Pharmaceuticals
Medtronic (MDT)
Quotient
Pacira Pharmaceuticals conv
Takeda Pharmaceutical (TAK)
Abbott Laboratories (ABT)
Zai Lab (ZLAB)

View all positions for Diag Capital Management

Top funds holding Zai Lab

Wellington Management Company
Henderson Group
Woodline Partners
Viking Global Investors
T. Rowe Price Associates
Bamco
Segantii Capital Management
FMR
Rock Springs Capital Management
ClearBridge Advisors
Legal & General Group
Citadel Advisors
Allianz Asset Management
BlackRock
Candriam Luxembourg S.C.A.

View all funds holding Zai Lab